Cure My Disease

Don't miss your cure!

 Log in / Sign up

Austrian study maps how lung, heart, and metabolic health interact

NCT ID NCT01727518

Knowledge-focused Sponsor: Ludwig Boltzmann Institute for Lung Health Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 17, 2026 · Last updated Sep 18, 2026 · Updated 1 time

Summary

The Austrian LEAD study follows a large group of people to understand how lung, heart, and metabolic health change over time. Researchers measure lung function with spirometry and track body composition and metabolic markers. By observing this group, they aim to learn how these conditions develop and relate to each other in the general population.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If the study succeeds, it could reveal how lung, heart, and metabolic health interact over time, which may help doctors spot risks earlier and design better prevention strategies.
What could go wrong
This is an observational study, so it can show patterns but cannot prove cause and effect. Findings may not apply to other populations, and the long follow-up means results take years to mature.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

14,966 people

The number who actually took part.

Started

Oct 2011

Expected to finish

Oct 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Community based cohort

Ages

6 to 80 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Male and Female, * Age 6 - 80 years, * Invitation by study invitation letter Exclusion Criteria: * Insufficient language skills * pregnancy

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Body composition, beneficial are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

glucocorticoid resistance Respiration Disorders respiratory system disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Body composition, beneficial Metabolic health Respiration disorders

Contacts and locations

Locations

  • The LEAD Study Center

    Vienna, 1140, Austria

More trials for these conditions

Other studies related to the condition(s) this trial covers.